Mural Oncology (MURA) Stock Forecast & Price Target

$3.45 -0.04 (-1.15%)

(As of 11/15/2024 ET)

Mural Oncology - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 4 Analyst Ratings

Sell
0

Hold
0

Buy
4

Based on 4 Wall Street analysts who have issued ratings for Mural Oncology in the last 12 months, the stock has a consensus rating of "Buy." Out of the 4 analysts, 3 have given a buy rating, and 1 has given a strong buy rating for MURA.

Consensus Price Target

$16.00
363.77% Upside

According to the 4 analysts' twelve-month price targets for Mural Oncology, the average price target is $16.00. The highest price target for MURA is $18.00, while the lowest price target for MURA is $13.00. The average price target represents a forecasted upside of 363.77% from the current price of $3.45.

Get the Latest News and Ratings for MURA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Mural Oncology and its competitors.

MURA Analyst Ratings Over Time

Type	Current Forecast 11/18/23 to 11/17/24	1 Month Ago 10/19/23 to 10/18/24	3 Months Ago 8/20/23 to 8/19/24	1 Year Ago 11/18/22 to 11/18/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	N/A
Buy	3 Buy rating(s)	3 Buy rating(s)	2 Buy rating(s)	N/A
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	N/A
Consensus Price Target	$16.00	$16.00	$14.00	N/A
Forecasted Upside	363.77% Upside	338.36% Upside	321.69% Upside	N/A
Consensus Rating	Buy	Buy	Buy	N/A

The only candlestick pattern worth a darn (Ad)

It’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again…

Follow this link here and enter your email address to sign up…

MURA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MURA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Mural Oncology Stock vs. The Competition

Type	Mural Oncology	Medical Companies	S&P 500
Consensus Rating Score	3.25	2.80	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	363.77% Upside	28,563.29% Upside	9.87% Upside
News Sentiment Rating	Neutral News See Recent MURA News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/11/2024	HC Wainwright 2 of 5 stars	A. Maldonado Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$18.00 ➝ $18.00	+411.36%
10/4/2024	Raymond James 4 of 5 stars	L. Prendergast Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Strong-Buy	$18.00	+462.50%
6/28/2024	Rodman & Renshaw 1 of 5 stars		Initiated Coverage	Buy	$15.00	+388.60%
4/4/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$13.00	+186.98%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 12:48 PM ET.

MURA Forecast - Frequently Asked Questions

: According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Mural Oncology is $16.00, with a high forecast of $18.00 and a low forecast of $13.00.
: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mural Oncology in the last twelve months. There are currently 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MURA shares.
: According to analysts, Mural Oncology's stock has a predicted upside of 363.77% based on their 12-month stock forecasts.
: Mural Oncology has been rated by research analysts at HC Wainwright, and Raymond James in the past 90 days.
: Analysts like Mural Oncology more than other "medical" companies. The consensus rating for Mural Oncology is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how MURA compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Why buying gold might be a mistake (Ad)

Something strange just happened with gold. With the recent Fed rate cut… My charts are showing a breakout signal I haven't seen in years. But for now, I'm not rushing to buy gold. In fact, I'm telling everyone I know to hold off. Because I believe there’s a far better way to play this upcoming surge. It's a method that could turn a 1% gold price change into gains like 59%, 118%, or even 228%. And it doesn't involve buying a single ounce of physical gold or even buying any regular gold stock. I've been trading gold for nearly 20 years now and this is my #1 recommended approach for trading gold right now. Most traders miss them completely… But for those who know how to spot them, it takes their trades to a whole new level.

If you're interested, check out the recording here while the link's still up.

This page (NASDAQ:MURA) was last updated on 11/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mural Oncology (MURA) Stock Forecast & Price Target